Latest Technology News

European Lithium Limited reports a maiden 45 million tonne rare earth resource at its Greenland Tanbreez Project, alongside a $24.5 million capital raise by its majority-owned Critical Metals Corp, underpinning its global lithium and rare earth ambitions.

Optiscan Imaging Ltd has revealed its next-generation InForm™ pathology imaging device and strengthened its executive team, while reporting a robust cash position supported by a $1.775 million R&D tax refund for the quarter ended 31 March 2025.

Jupiter Mines reported a robust Q3 FY2025 with higher manganese production and sales at Tshipi, driving a 65% jump in EBITDA amid improved prices and reduced costs.

Aldoro Resources has reported significant assay results from its Kameelburg project in Namibia, confirming a large polymetallic deposit rich in rare earth elements, niobium, and molybdenum. The discovery, characterized by extensive mineralization and strategic metal zonation, is shaping up as a potential Tier 1 resource with strong commercial appeal.

AnteoTech Ltd reports progress in advanced battery and life sciences technologies alongside a strategic review and leadership changes amid challenging EV market conditions.

Syntara Limited reports significant clinical progress with its lead myelofibrosis drug SNT-5505 and launches a new trial for its next-generation anti-fibrotic skin treatment, supported by a solid $18 million cash reserve.

Powerhouse Ventures Limited reports a robust start to 2025, highlighted by strong fund performance, a successful capital raise, and strategic business expansion despite market volatility.

Anteris Technologies Global Corp. has filed an amended 10-K to disclose comprehensive governance, executive pay, and related party transactions for fiscal 2024, completing its annual SEC reporting obligations.

Galan Lithium has locked in a binding funding and offtake agreement with Authium Limited for its Hombre Muerto West project, significantly reducing capital and operating costs. The company raised approximately A$13 million via placement and plans further shareholder funding, aiming for lithium chloride production in H1 2026.

Noxopharm Limited has successfully cleared key preclinical hurdles for its SOF-SKN™ lupus drug and expanded its Sofra™ platform collaborations, supported by fresh funding to propel upcoming clinical trials.

Gratifii Limited reported a record quarterly cash receipt surge of 111% year-on-year, driven by key contract wins and successful platform migration despite cyclone disruptions. The company advances its post-merger integration and eyes an $84m revenue run rate in FY26.

Aurora Labs has completed the design and initial testing of its AU4 40kg thrust micro gas turbine, marking a significant step in UAV propulsion technology. The company is now focusing on scaling production and deepening defence sector partnerships following strong international engagement.